H-Wave® by Electronic Waveform Lab, Inc.

Apr 25, 2011		Los Angeles Lakers "Training Room Tips" Features H-Wave The Lakers website contains a Training Room Tips page featuring head athletic trainer Gary Vitti. The latest Training Room Tip is on electric stimulation machines where Gary Vitti explains that the device used most by the Los Angeles Lakers for pain and inflammation is the H-Wave. Gary Vitti goes on to explain that the H-Wave uses a very special current and demonstrates its use on a knee injury. The Lakers Training Room Tips page can be found at: http://www.nba.com/lakers/news/1011trainingtips.html The electric stimulation video specifically can be found at: http://www.nba.com/lakers/video/2011/04/18/BlueGooElectricStimMachine1-1652952
Feb 06, 2011		Congratulations to the Green Bay Packers; a Valued H-Wave Customer! All of us at H-Wave would like to congratulate the Green Bay Packers for their 31-25 victory over the Pittsburgh Steelers in Super Bowl XLV. The Packers are long time H-Wave customers and own 21 portable H-Wave devices that are used regularly by players and training staff. We are proud to have the Packers as one of our largest pro sports customers and wish them all the best!
Oct 29, 2009		Double Blind Post Operative Study Utilizing H-Wave® This is the first randomized double-blind placebo controlled prospective study that assessed the effects of H-Wave device stimulation (HWDS) on range of motion and strength testing in patients who underwent rotator cuff reconstruction. Patients who received HWDS compared to Placebo demonstrated, on average, significantly improved range of motion. At 90 days post op those that utilized H-Wave had 46.1% less loss of external rotation compared to those without H-Wave. At 90 days post op those that used H-Wave had 42.7% less loss of internal rotation compared to those without H-Wave. Albeit the small sample size, statistical analysis has shown that patients who have undergone rotator cuff reconstruction and used HWDS daily compared to Placebo (sham) post operatively, have benefited by increased range of meotion and possibly strenght. BMC Musculoskeletal Disorders. 2009 Oct 29;10(1):132 PMID: 19874593
Sep 29, 2009		Wake Forest University Publishes MOA Reseach Thomas L Smith a leading vascular researcher from Wake Forest University has published an article on the Mechanisms of Action of the H-Wave® Device. In September of 2009 the Journal of Orthopaedic Research published an article entitled: H-Wave induces arteriolar vasodilation in rat striated muscle via nitric oxide-mediated mechanisms. The researched hypthesized that H-Wave (HWDS) induces arteriolar dilation, a mechanism involved in the healing process. Acute effects of HWDS on striated muscle arterilar diameters were stuided. In a separate cohort, the role of nitric oxide (NO) in the response to HWDS was assessed by blocking NO. HWDS resulted in significant arteriolar vasodilation. The arterioles in the sham animals demonstrated no changes in diameter. In addition, lack of arteriolar dilation following HWDS with blockade of NO production suggests that NO plays a role in the microvascular response to HWDS. The authors states that these studies suggest that arteriolar vasodilation accompanying HWDS may result in increased perfusion, contribuing to the observed therapeutic effects of HWDS. Journal of Orthopaedic Research. Pg 1248-1251. Sept 2009.
Mar 13, 2009		H-Wave® Mechanism of Action Described In Published Article The Physician and Sports Medicine Journal has published an article entitled: The H-Wave® Device Induces NO Dependent Augmented Microcirculation and Angiogenesis, Providing Both Analgesia and Tissue Healing in Sports Injuries. The articles reviews a number of H-Wave studies including recently completed research on the mechansisms of this intervention. The aim of a number of animal studies conducted at Wake Forest University School of Medicine was to directly assess striated muscle microvascular responses to H-Wave (HWDS). H-Wave device stimulation reslted in signficant arteriolar vasodilation, which suggests that this treatment modality is associated with significant increases in striated muscle perfusion. In addition, the effect of repeated stimulation over a 3-week period on hind limb blood flow was also assessed. H-Wave device stimulation of the conditioned hindlimb elicited an average 247% increase in limb blood flow above resting conditions. Subsequent analysis of the conditioned hind limb for the production of new vessels resulted in a demonstrable increase in new blood vessels proving angiogenesis in the region. The authors hypothesized that because of these innate properties, it may provide a paradigm shift for the treatment of both short and long term inflammatory conditions associated with pain. The Physician and Sports Medicine. Volume 36. Number 1. December 2008. ISSN 0091-3847.
Feb 09, 2009		Wake Forest University Dept of Orthopedic Surgery Publishes H-Wave® Research The Journal of Orthopedic Research has published the abstract of a recently accepted paper on the mechanisms of the H-Wave® device. Lead researcher Thomas L. Smith, PhD and his team have had a paper accepted for publication entitled: H-Wave® induces arteriolar vasodilation in rat striated muscle via nitric oxide mediated mechanisms. The research recognizes the use of H-Wave® to expedite recovery from soft tissue injuries and aims to learn more about exactly how and why the H-Wave® device is particularly effective. Smith and his team found that H-Wave® device stimulation (HWDS) resulted in significant arteriolar vasodilation, which is a mechanism involved in the healing process; and noted that nitric oxide plays a role in the microvascular response to HWDS. Their research suggests that arteriolar vasodilation accompanying HWDS may result in increased perfusion, contributing to the observed therapeutic effects of HWDS.
Jul 19, 2008		First Meta-Analysis on the H-Wave® Device is Published A meta-analysis combines the results of several studies that address a set of related topics. Resulting overall averages can be considered meta-effects sizes, which are more powerful estimates of the true effect size than those derived in a single study. For this reason the medical community often relies on meta-analysis’ to more accurately evaluate the effectiveness of medical interventions. In July 2008 Springer Healthcare Communications peer reviewed journal Advances in Therapy published an article entitled: The H-Wave® Device Is an Effective and Safe Non-Pharmacological Analgesic for Chronic Pain: a Meta-Analysis. “This meta-analysis was conducted to systematically review the efficacy and safety of the H-Wave® (Electronic Waveform Lab, Inc, Huntington Beach, CA USA) device and programme as a non-pharmacological analgesic treatment in chronic soft tissue inflammation and neuropathic pain.” “The findings suggest that the H-Wave® device has moderate to strong effects in relieving pain, reducing the requirement for pain medication, and improving functionality in patients with chronic soft tissue inflammation and neuropathic pain, and that these effects are significant across all analyzed studies.” “The most robust effect was observed for improved functionality, suggesting that the H-Wave® device may facilitate a quicker return to work and other related daily activities.” Springer Healthcare Communications. Advances in Therapy. July 2008. V25. N7
Oct 22, 2007		H-Wave® research presented at the 6th Combined Meeting of the Orthopedic Research Societies. On Monday October 22nd at the 6th Combined Meeting of the Orthopedic Research Societies in Honolulu, HI a presentation was given on H-Wave. Tom Smith, PhD. (Orthopaedic Surgery, Wake Forest University School of Medicine) presented his current research entitled: The microvascular and hemodynamic mechanisms for the therapeutic actions of H-Wave® muscle stimulation. The aim of this scientific animal research was to directly assess striated muscle microvascular responses to H-Wave stimulation. In addition, the effect of repeated stimulation over a three week period on hindlimb blood flow was assessed. Research showed that H-Wave treatment resulted in significant arteriolar vasodilation and increased blood flow to the limb by 200%. It was demonstrated that this microvascular response was mediated, at least in part by nitric oxide. When the limb was conditioned by daily (M-F) treatments for 3 weeks limb blood flow increased by 247%. This increase in blood flow in the conditioned limb suggests an increased vascular reserve available for augmenting perfusion in the limbs exposed to repetitive H-Wave treatments. Further analysis showed that angiogenesis indeed occurred in the limbs that received repetitive H-Wave treatments. Paper No. 83. 6th Combined Meeting of the Orthopedic Research Societies
Dec 15, 2006		Extended population study published on the benefits of home H-Wave® A peer reviewed and highly indexed journal (including PubMed and Medline) published an article regarding the H-Wave device entitled: “The H-Wave Small Muscle Fiber Stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study” The study analyzed the results of 6,774 patients that used home H-Wave devices. 65% of participants reported a reduced or eliminated need for pain medication; 79% reported improved functional capacity or activity; and 78% reported 25% or greater reduction of pain. All enrolled patients had previous physician-documented diagnosis of chronic soft-tissue injury or neuropathic pain in an upper or lower extremity or the spine that was unresponsive to conventional therapy. Results of this expanded population study suggest the H-Wave device can provide a potential first-line nonpharmacologic alternative to the treatment of common painful and inflammatory conditions. By reducing or eliminating the need for medication and restoring physical functioning, this novel approach may not only enhance the quality of life of any patients who suffer soft-tissue injuries and neuropathic pain, but it may also reduce the social and economic costs associated with these chronic pain syndromes. Advances in Therapy. Volume 23 No. 5. September/October 2006
Jul 03, 2006		Peer-reviewed outcome study is published on the benefits of H-Wave®. The journal Advances in Therapy® has published an article entitled: “H-Wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study.” The purpose of the study was to evaluate the H-Wave device in patients with persistent pain associated with injuries or conditions affecting the upper or lower extremities or the back. The study concludes that potential benefits of treatment include substantial pain relief, reduced medication requirements, and improved levels of function and activity. All patients had previously been treated with other analgesic modalities, including medications, physical therapy, and TENS, and all had attained inadequate pain relief. The study included 1,291 patients all of which had a baseline pain score >5 (out of 10) and had a history of previous pain therapy. Advances in Therapy. May/June 2006. V23 N3. 446-455.
Jul 08, 2005		Leading sports medicine specialist discusses H-Wave® in new book. Framework Your 7-Step Program For Healthy Muscles, Bones, and Joints was written by Nicholas A. DiNubile, MD, the nation’s leading sports medicine specialist. The foreword was written by Governor Arnold Schwarzenegger, who states “It’s a must read for anyone who cares about his or her body, and wants it to last.” The book points out the ability of H-Wave to manage pain, improve lymphatics, and optimize the environment for a quicker recovery. Dr. DiNubile discusses his constant use of H-Wave on injured Philadelphia 76ers players, whom he consults for. The book also states that Gary Vitti, the highly respected trainer for the Los Angeles Lakers, feels that H-Wave is indispensable in keeping his guys above the rim. Jeffrey Spencer, DC, who works with Lance Armstrong and the US Postal Pro Cycling Team, says he wouldn’t leave home without it (H-Wave).
May 15, 2005		Medical Hypotheses Journal publishes article on properties and uniqueness of H-Wave®. The Medical Hypotheses Journal has published an article entitled “Innate Properties of H-Wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies by affecting tissue circulation: a hypothesis.” The article discusses the unique properties of the H-Wave device and how H-Wave may represent a more optimal stimulation for circulation and pain control. Medical Hypotheses, Volume 64, Issue 5, 2005.
May 01, 2002		Healthcare book entitled Validate Your Pain discusses success and uniqueness of H-Wave® device. Validate Your Pain: Exposing the Chronic Pain Cover-Up was written by Alan F. Chino, Ph.D. and Corinne D. Davis, M.D. The book distinguishes H-Wave as a unique type of electrical stimulation and discusses the success in managing acute and chronic pain conditions as well as success in improving circulation. The book cites practitioners’ reports that with use of the H-Wave there is a decrease in costly trips to the emergency room as well as a reduction in the amount of narcotics taken by patients to manage pain. It also cites that in one study, the continued use of H-Wave over a prolonged period of time strongly suggests long-term benefit.